黄片在线免费观看,欧美在线无码精品秘 蜜桃.,苍井空一级婬片A片,精品人妻一区二区三区日产乱码,鲁大师在线观看日本影片

English

ENDPOINTSNEWS: On a quest to challenge Novo Nordisk in obesity, transpacific startup picks up $70M — and a pair of seasoned execs

2021-10-13

新聞截圖.png

— AUTHOR: Amber Tong, Senior Editor

— REPRINTED FROM ENDPOINTSNEWS

— ORIGINAL LINK: https://endpts.com/on-a-quest-to-challenge-novo-nordisk-in-obesity-transpacific-startup-picks-up-70m-and-a-pair-of-seasoned-execs/

Four years after starting Terns Pharmaceuticals together in search of an elusive NASH win, Weidong Zhong and Martijn Fenaux are reuniting at a new startup.

On paper, Sciwind Biosciences — which just raised $70 million in Series C cash — employs a similar setup as Terns: Both have embraced the transpacific model, taking root in China but planting flags in the US.

Zhong was tapped to be president of the San Francisco-based subsidiary back in July, on top of assuming the role as chief strategy officer. Weeks later, Fenaux has been appointed SVP, nonclinical development and translational science at the parent company out of Hangzhou — joining the team alongside chief scientific officer Xinle Wu, who brings experience running R&D for both Eli Lilly and Amgen in China.

Whereas Terns is focused on NASH and other liver diseases, Sciwind positions itself as a specialist in metabolic disorders. The three lead candidates all congregate around GLP-1 receptor agonism, a mechanism that Sciwind reckons is relevant across fatty liver, obesity and diabetes.

The new infusion marks Sciwind’s second financing in a year, having bagged $37 million in February to fuel the clinical work underway for XW003 (long-acting GLP-1 peptide analog) in type 2 diabetes and obesity. Topline Phase II data are expected in the second half of 2022.

To reach those massive markets, the biotech would first have to steer past giant rivals like Novo Nordisk, whose GLP-1 peptide analog semaglutide is already approved in the US for both of those indications.

Then there's the follow-on XW004, which is designed for once daily rather than once weekly administration, slated for first-in-human trials later this year; and XW014, a preclinical small molecule GLP-1R agonist.

But IDG Capital, Loyal Valley Capital and LYFE Capital have no trouble believing in Sciwind and founder/CEO Hai Pan, leading the latest round.

久久欧美国产伦子伦精品 | 亚洲一级 片内射无码 | 影音先锋资源在线观看 | 欧美性猛交老妇一级A片 | 国产激情视频在线观看 | 欧美不卡一区二区三区 | 欧美精品黑人猛交高潮 | 国产精品粉嫩+91在线++B | 強行糟蹋人妻HD中文 | 国产对白叫床清晰在线播放 | 毛片在线免费观看网站 | 亚洲AV无码蜜桃希岛爱理 | 视频在线观看免费高清黄 | 99国产揄拍国产精品 | 国产又黄又爽无码无遮拦 | 国产又粗又爽又大视频 | 好爽射深一点丰满视频 | 黄色成人网站在线观看 | 日本人妻系列无线码在线 | 国产mv在线观看免费 | 国产黄色视频免费观看 | 午夜成人精品一二三区 | 粉嫩娇妻无码视频在线观看 | 久久久久久亚洲精品 | 成人国产AV无码一区二区 | 亚洲A V电影一区 | 天天夜夜一级A片免费看 | 伊人中文字幕在线观看 | 日本人妻出軌不倫A片 | 免费看欧美A级黄色绿像 | 精品无码人妻一区二区免费蜜桃 | 99久久无码一区人妻贼王 | 亚洲无码在线观看高清视频 | 搡老女人老91妇女老熟女 | 国产偷窃熟妇毛多水有多 | 红桃视频一区二区三区免费 | 自慰喷水www久久天堂 | 国产与黑人一级A片免费 | 国产太孟太爽太大太长视片 | 成人精品鲁一区一区二区 | 免费无遮挡无码永久在线观看视频 |